Cerivastatin sodium

This classification denotes a hmg-coa reductase inhibitor with the molecular formula C26H33FNO5.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Q18G1060S, chemically known as 6-heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, (s-(r*,s*-(e)))- but more generally known as cerivastatin sodium, which bears US NIH Compound Identifier 446156. European Medicines Agency schedules Cerivastatin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13294MIG. Most nations, for tariff and trade purposes, schedule cerivastatin sodium under HS 29333999 and SITC 51574. As of Q4 2014, CERIVASTATIN SODIUM remains US FDA's Preferred Term for this commodity. Cerivastatin sodium bears US NLM identifiers UMLS ID C0724549 and NCI Concept Code C28919. SMILES: CC(C)C1C(C(C(C(N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)COC.[NA+].